SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

AST Spacemobile, Inc. engages in building a broadband cellular network in space to operate directly with standard, unmodified mobile devices based on an extensive IP and patent portfolio. It focuses on providing mobile broadband services with global coverage to all end-users, without the need to purchase special equipment. The company was founded by Abel Avellan on May 31, 2017 and is headquartered in Midland, TX.

AST SpaceMobile Inc - Ordinary Shares - Class A

AST SpaceMobile Inc

AST SpaceMobile is facing significant downward pressure following a launch anomaly where Blue Origin's New Glenn rocket failed to place a BlueBird satellite into the correct orbit. While the community is actively debating the impact of this setback on launch timelines and partner reliability, investors are divided between capitalizing on the dip as an overreaction to an insured event and concerns regarding execution risks versus established industry competitors.

POET Technologies, Inc. engages in the designing, developing, manufacturing and sale of opto-electronic solutions for the sensing, data communications and telecommunications markets. It developed POET Optical Interposer platform, which allows the integration of electronic and photonic devices into a single multi-chip module. The company was founded on November 14, 1985 and is headquartered in Toronto, Canada.

POET Technologies Inc

POET Technologies is seeing high volatility driven by a short-seller report that has triggered intense community debate regarding the company's tax status and growth narrative. Investors are actively discussing the firm's response to these claims, alongside optimistic sentiment surrounding its recent technological partnerships and upcoming strategic shifts.

USA Rare Earth, Inc. is domestic supplier of rare earth magnets and heavy rare earth elements. It is developing a vertically integrated, domestic supply chain for rare earth element magnet production, with a facility in Stillwater, Oklahoma, and mining rights to the Round Top heavy rare earth and critical minerals deposit in West Texas. The company was founded in May 2019 and is headquartered in Stillwater, OK.

USA Rare Earth Inc. - Ordinary Shares - Class A

USA Rare Earth Inc

USA Rare Earth is trending as investors react to a strategic $2.8 billion acquisition of Brazil's Serra Verde Group, a move designed to secure critical supply chain independence for magnetic rare earths. While the community is actively debating the short-term impact of the stock-and-cash dilution, broader sentiment remains focused on the company's long-term potential as a U.S.-backed infrastructure play for the defense, EV, and AI sectors.

Newcourt Acquisition Corp. is a blank check company, which engages in the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. The company was founded on February 25, 2021 and is headquartered in Oakland, CA.

Psyence Biomedical Ltd.

Psyence Biomedical is experiencing massive social media buzz following an executive order that fast-tracks research for psychedelic therapies, with the community highlighting its focus on Ibogaine as a primary catalyst. Investors are actively debating the stock's potential for a short squeeze due to its low float and limited share availability, as strong sentiment clashes with warnings about the inherent volatility of micro-cap biotech trading.

Adobe, Inc. is a global technology company, which engages in the provision of digital marketing and media solutions. It operates through the following segments: Digital Media, Digital Experience, and Publishing and Advertising. The Digital Media segment offers products and services that enable individuals, teams, businesses, and enterprises to create, publish, and promote content anywhere and accelerate productivity by transforming view, share, engage with and collaborate on documents and creative content. The Digital Experience segment focuses on integrated platform and set of products, services, and solutions that enable businesses to create, manage, execute, measure, monetize, and optimize customer experiences that span from analytics to commerce. The Publishing and Advertising segment includes legacy products and services that address diverse market opportunities, including eLearning solutions, technical document publishing, web conferencing, document and forms platform, web app development, high-end printing, and Adobe Advertising offerings. The company was founded by Charles M. Geschke and John E. Warnock in December 1982 and is headquartered in San Jose, CA.

Adobe Inc

Adobe is facing intense market volatility as investors weigh the potential of its AI-driven enterprise tools against fears that generative AI could disrupt its established creative software moat. The stock is currently experiencing significant downward pressure as the community debates whether the recent sell-off represents an irrational disconnect from elite fundamentals or a structural shift in the software landscape.

Candel Therapeutics, Inc. is a clinical stage biotechnology company, which engages in the development and commercialization of viral immunotherapies. Its pipeline includes CAN-2409 and CAN-3110. The company was founded by Estuardo Aguilar-Cordova in 2002 and is headquartered in Needham, MA.

Candel Therapeutics Inc

Candel Therapeutics is trending as investors focus on its potential as a breakthrough in cancer immunotherapy, bolstered by positive clinical trial data and recent analyst coverage projecting significant peak sales. The community is actively debating the company's valuation relative to its pipeline, with bullish sentiment driven by anticipation of upcoming prostate cancer data reveals and the possibility of strategic partnerships or buyout interest.

Atai Beckley, Inc. is a clinical-stage biopharmaceutical company focused on developing effective, rapid-acting, and convenient mental health treatments. The company is headquartered in New York, NY.

AtaiBeckley Inc.

ATAI Life Sciences N.V.

ATAI Life Sciences is trending as shares rally following a new executive order signed by the President to accelerate the review and funding of psychedelic drug research for mental health treatments. The community is actively discussing the potential for a massive repricing or buyout, with many traders closely watching for institutional activity and the upcoming Phase 3 clinical trial developments.

BlackBerry Ltd. engages in the provision of intelligent security software and services. It operates through the following segments: Cybersecurity, Internet of Things (IoT), and Licensing and Other. The Cybersecurity segment includes the brand Cylance, BlackBerry Spark, AtHoc, and SecuSUITE. The IoT segment focuses on software licenses, support, maintenance, and professional services. The Licensing and Other segment involves the intellectual property licensing arrangements and settlement awards. The company was founded by Michael Lazaridis, James Laurence Balsillie, and Douglas E. Fregin on March 7, 1984 and is headquartered in Waterloo, Canada.

BlackBerry Ltd

BlackBerry is trending as investors react to a significant expansion of its partnership with NVIDIA to power safety-critical edge AI systems for robotics and industrial applications. The community is actively discussing the stock's potential for a broader valuation reset, with many highlighting the companys transition from a legacy name to a vital infrastructure play in the physical AI sector.

Cleveland-Cliffs, Inc. is a flat-rolled steel company, which engages in provision of iron ore pellets to the North American steel industry. It focuses on the production of metallic and coke, iron making, steelmaking, rolling and finishing, and downstream tubular components, stamping, and tooling. It operates through the Steelmaking and Other Businesses segments. The company was founded in 1847 and is headquartered in Cleveland, OH.

Cleveland-Cliffs Inc

Cleveland-Cliffs is facing heightened volatility and selling pressure as investors weigh mixed earnings results against concerns regarding management's strategic vision and potential deal uncertainty. The community is actively debating the company's long-term debt position and the sustainability of its business model, while some traders closely monitor technical indicators for signs of a reversal or a possible breakout.

Compass Pathways Plc is a biotechnology company, which provides mental health care services. It focuses on improving the lives of those who are suffering with mental health challenges and who are not helped by current treatments. The company was founded by Goldsmith George Jay and Malievskaia Ekaterina in 2016 and is headquartered in London, the United Kingdom.

Compass Pathways Plc - ADR

COMPASS Pathways

COMPASS Pathways (CMPS) and peers in the psychedelic biotech space are surging following an executive order from President Trump designed to accelerate research and FDA review pathways for mental health treatments. While the sector is experiencing high-conviction momentum and institutional interest, community discourse remains divided between those betting on long-term clinical success and those wary of volatility and the potential for short-term speculative 'pump and dump' dynamics.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Alignment Healthcare, Inc. (NASDAQ:ALHC) Receives Consensus Recommendation of "Moderate Buy" from Analysts

Alignment Healthcare, Inc. (NASDAQ:ALHC - Get Free Report) has been assigned an average recommendation of "Moderate Buy" from the eleven analysts that are presently covering the company, Marketbeat...

Alignment Healthcare (NASDAQ:ALHC) Now Covered by Wolfe Research

Wolfe Research initiated coverage on shares of Alignment Healthcare in a research note on Friday. They issued an "outperform" rating and a $24.00 price target on the stock...

Alignment Healthcare (NASDAQ:ALHC) President Dawn Christine Maroney Sells 30,000 Shares

Alignment Healthcare, Inc. (NASDAQ:ALHC - Get Free Report) President Dawn Christine Maroney sold 30,000 shares of the company's stock in a transaction that occurred on Wednesday, April 15th. The stock was sold at an average price of $20.87, for a total transaction of $626,100.00. Following the...

Alignment Healthcare (NASDAQ:ALHC) President Sells $626,100.00 in Stock

Alignment Healthcare, Inc. (NASDAQ:ALHC - Get Free Report) President Dawn Christine Maroney sold 30,000 shares of the stock in a transaction on Wednesday, April 15th. The stock was sold at an average price of $20.87, for a total value of $626,100.00. Following the completion of the sale, the...

Alignment Healthcare (NASDAQ:ALHC) CEO John Kao Sells 82,299 Shares

Alignment Healthcare, Inc. (NASDAQ:ALHC - Get Free Report) CEO John Kao sold 82,299 shares of the stock in a transaction that occurred on Monday, April 13th. The stock was sold at an average price of...

John Kao Sells 215,701 Shares of Alignment Healthcare (NASDAQ:ALHC) Stock

Alignment Healthcare, Inc. (NASDAQ:ALHC - Get Free Report) CEO John Kao sold 215,701 shares of Alignment Healthcare stock in a transaction that occurred on Friday, April 10th. The shares were sold at an average price of $20.63, for a total transaction of $4,449,911.63. Following the sale, the chief...

Insider Selling: Alignment Healthcare (NASDAQ:ALHC) CEO Sells 82,299 Shares of Stock

Alignment Healthcare, Inc. (NASDAQ:ALHC - Get Free Report) CEO John Kao sold 82,299 shares of the stock in a transaction on Monday, April 13th. The stock was sold at an average price of $20.80, for a total value of $1,711,819.20. Following the transaction, the chief executive officer owned...

John Kao Sells 250,000 Shares of Alignment Healthcare (NASDAQ:ALHC) Stock

Alignment Healthcare, Inc. (NASDAQ:ALHC - Get Free Report) CEO John Kao sold 250,000 shares of the business's stock in a transaction that occurred on Tuesday, April 7th. The shares were sold at an...

Tudor Investment Corp ET AL Sells 865,720 Shares of Alignment Healthcare, Inc. $ALHC

Tudor Investment Corp ET AL trimmed its position in shares of Alignment Healthcare, Inc. (NASDAQ:ALHC - Free Report) by 76.0% during the third quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 273,01...

Alignment Healthcare (NASDAQ:ALHC) CEO Sells $5,252,500.00 in Stock

Alignment Healthcare, Inc. (NASDAQ:ALHC - Get Free Report) CEO John Kao sold 250,000 shares of the stock in a transaction that occurred on Tuesday, April 7th. The stock was sold at an average price...

Alignment Healthcare, Inc. is a holding company, which offers a consumer-centric platform that delivers customized health care solutions to seniors and those who need it most, the chronically ill and frail, through its Medicare Advantage plans. It offers health plan options through Alignment Health Plan, and partners with select health plans to help deliver better benefits at lower costs. The company was founded by John E. Kao in 2013 and is headquartered in Orange, CA.

Current Price	$21.55
Prev Close	$21.22
Open	$21.30
Dividend Yield	0.00%
50-Day Moving Average	$19.28
Beta	0.44
Avg. Volume	3.32M
PE Ratio	-2,306.52

52-Week High	$23.87
52-Week Low	$11.63
Market Capitalization	$4.34B
EPS (Annual)	-$0.0037
Price to Book	24.16
Revenue Per Employee	$2.14M

ALHC
Alignment Healthcare Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest ALHC News

ALHCAlignment Healthcare Inc